Maternal RSV vaccine protects mothers and babies

In the news:

RSV vaccines of mothers during pregnancy provides a 78 to 81 percent reduction in RSV-associated hospitalisation of babies from birth through 6 months of age.

An analysis of the headline news of the latest study on cholesterol lowering drugs for people over 70 years of age.

A clarification on our reporting of the two measles-associated deaths in Pennsylvania from last week's story.

References

Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants

New England Journal of Medicine: Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults

The BMJ: Measles: CDC refuses to record Pennsylvania fatalities in “measles associated deaths” row